Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension
The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Animal studies have shown that oxidative stress and renal tubulointerstitial inflammation are associated with, and have major roles in, the pathogenesis of hypertension. This view is supported by the observations that alleviation of oxidative stress and renal tubulointerstitial inflammation reduce arterial pressure in animal models. Conversely, hypertension has been shown to cause oxidative stress and inflammation in renal and cardiovascular tissues in experimental animals. Taken together, these observations indicate that oxidative stress, inflammation and arterial hypertension participate in a self-perpetuating cycle which, if not interrupted, can lead to progressive cardiovascular disease and renal complications. These events usually occur in an insidious and asymptomatic manner over an extended period following the onset of hypertension. Severe target organ injury can, however, occasionally occur precipitously in the course of malignant or accelerated hypertension. Given the high degree of heterogeneity of hypertensive disorders, the factor(s) initiating the vicious cycle described vary considerably in different forms of hypertension. For instance, oxidative stress in the kidney and vascular tissue is the primary mediator in the pathogenesis of angiotensin-induced, and perhaps lead-induced, hypertension. By contrast, increased arterial pressure is probably the initiating trigger in salt-sensitive hypertension. Although the initiating factor might vary between hypertensive disorders, according to the proposed model, the three components of the cycle eventually coalesce in all forms of hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there have been some successes (e.g. [1633]), the results have generally been decidedly mixed, with little clinical benefit (or even actual disbenefit) following from their administration [692,1588,1634-1639]”
Citations
Cites
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Antioxidant and redox regulation of gene transcription
Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,981 · cited 1×
“NFκB serves as the general transcription factor for several pro-inflammatory cytokines, chemokines and adhesion molecules, and is activated by micromolar concentrations of H 2 O 2”
BackgroundVitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1560 · Cited by 901
Oxidative Stress as a Regulator of Gene Expression in the Vasculature
Kunsch, C., & Medford, R. M. (1999) · Circulation Research · doi:10.1161/01.res.85.8.753 · Cited by 799 · cited 1×
“Reduced bioavailability of NO supports development and maintenance of hypertension by the following mechanisms: increased systemic vascular resistance (attenuation of NO-mediated vasodilatory tone); increased adrenergic tone (reduction of NO-mediated inhibition of central sympathetic outflow); volume expansion (attenu…”
BackgroundLinks Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases
Meneton, P., Jeunemaitre, X., de Wardener, H. E., & Macgregor, G. A. (2005) · Physiological Reviews · doi:10.1152/physrev.00056.2003 · Cited by 703 · cited 1×
“The combination of renal inflammation, oxidative stress and angiotensin II drives salt retention, resulting in volume expansion, increased cardiac output and systemic vascular resistance”
BackgroundRey, F. E., Cifuentes, M. E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 605
Role of p47 phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II
Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., Holland, S. M., & Harrison, D. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000032100.23772.98 · Cited by 577
Effects of exercise and diet on chronic disease
Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556 · cited 1×
“Moreover, regular exercise helps to fortify the antioxidant defense system by upregulating production of antioxidant enzymes, increasing NO production, enhancing insulin sensitivity, improving endothelial function and lipid profiles, and increasing plasma levels of HDL”
BackgroundLandmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., Kohler, C., Harrison, D. G., Hornig, B., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000041431.57222.af · Cited by 516
Takahashi, K., Nammour, T. M., Fukunaga, M., Ebert, J., Morrow, J. D., Roberts, L. J., Hoover, R. L., & Badr, K. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115826 · Cited by 511
Kol, A., Bourcier, T., Lichtman, A. H., & Libby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5310 · Cited by 510 · cited 1×
“which in turn stimulate production of pro-inflammatory cytokines and expression of the adhesion molecules E-selectin, intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1)”
BackgroundHyperuricemia in Primary and Renal Hypertension
Cannon, P. J., Stason, W. B., Demartini, F. E., Sommers, S. C., & Laragh, J. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609012750902 · Cited by 505
Schnackenberg, C. G., Welch, W. J., & Wilcox, C. S. (1998) · Hypertension · doi:10.1161/01.hyp.32.1.59 · Cited by 498
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Wilcox, C. S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00250.2005 · Cited by 481
McNally, J. S., Davis, M. E., Giddens, D. P., Saha, A., Hwang, J., Dikalov, S., Jo, H., & Harrison, D. G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00515.2003 · Cited by 461
Sydow, K., & Münzel, T. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00033-3 · Cited by 433
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
Chen, X., Touyz, R. M., Park, J. B., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.094005 · Cited by 410
NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats
Muller, D. N., Dechend, R., Mervaala, E. M. A., Park, J.-K., Schmidt, F., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.193 · Cited by 405
Induction of Oxidative Stress by Glutathione Depletion Causes Severe Hypertension in Normal Rats
Vaziri, N. D., Wang, X. Q., Oveisi, F., & Rad, B. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.142 · Cited by 400 · cited 1×
“Finally, induction of oxidative stress causes hypertension in genetically normal and otherwise healthy animals”
BackgroundSelf-citationChabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., & Wilcox, C. S. (2002) · Hypertension · doi:10.1161/hy0202.103264 · Cited by 377
Schnackenberg, C. G., & Wilcox, C. S. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.424 · Cited by 375
Regulation of Intrarenal Angiotensin II in Hypertension
Navar, L. G., Harrison-Bernard, L. M., Nishiyama, A., & Kobori, H. (2002) · Hypertension · doi:10.1161/hy0202.103821 · Cited by 375
KOJDA, G., & HAMBRECHT, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.032 · Cited by 368 · cited 1×
“Moreover, regular exercise helps to fortify the antioxidant defense system by upregulating production of antioxidant enzymes, increasing NO production, enhancing insulin sensitivity, improving endothelial function and lipid profiles, and increasing plasma levels of HDL”
BackgroundOxidative stress in uremia: Nature, mechanisms, and potential consequences
Vaziri, N. D. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.06.026 · Cited by 355
Self-citationNADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat
Beswick, R. A., Dorrance, A. M., Leite, R., & Webb, R. C. (2001) · Hypertension · doi:10.1161/hy1101.093423 · Cited by 347
Redox Mechanisms in Blood Vessels
Mueller, C. F. H., Laude, K., McNally, J. S., & Harrison, D. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000149143.04821.eb · Cited by 342
Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency
Vaziri, N. D., Dicus, M., Ho, N. D., Boroujerdi-Rad, L., & Sindhu, R. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00702.x · Cited by 335
Self-citationTreatment of hypertension with ascorbic acid
Duffy, S., Gokce, N., Holbrook, M., Huang, A., Frei, B., Keaney, J. F., & Vita, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04410-4 · Cited by 333 · cited 1×
“Finally, a role of oxidative stress in the pathogenesis of human hypertension is supported by the results of a randomized double-blind clinical trial that demonstrated a significant reduction in arterial pressure with antioxidant therapy (ascorbic acid)”
ResultRuiz-Ortega, M., Lorenzo, O., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331
Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.022 · Cited by 322 · cited 1×
“Hypertension, oxidative stress and NO availability improve within 2 months of animals switching to a normal diet”
BackgroundSelf-citationPYELONEPHRITIS: ITS RELATION TO VASCULAR LESIONS AND TO ARTERIAL HYPERTENSION
WEISS, S., & PARKER, F. (1939) · Medicine · doi:10.1097/00005792-193909000-00001 · Cited by 321
Salt Intake, Oxidative Stress, and Renal Expression of NADPH Oxidase and Superoxide Dismutase
Kitiyakara, C., Chabrashvili, T., Chen, Y., Blau, J., Karber, A., Aslam, S., Welch, W. J., & Wilcox, C. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092145.90389.65 · Cited by 310 · cited 1×
“by a low-sodium diet) does not cause oxidative stress or inflammation”
BackgroundAngiotensin II as a renal growth factor.
Wolf, G., & Neilson, E. G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391531 · Cited by 307
Lacy, F., Kailasam, M. T., O’Connor, D. T., Schmid-Schönbein, G. W., & Parmer, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.878 · Cited by 299 · cited 1×
“The plasma concentration of H 2 O 2 is elevated in patients with essential hypertension”
BackgroundRoberts, C. K., Vaziri, N. D., & Barnard, R. J. (2002) · Circulation · doi:10.1161/01.cir.0000040584.91836.0d · Cited by 293
Self-citationImmunosuppressive Treatment Protects Against Angiotensin II-Induced Renal Damage
Muller, D. N., Shagdarsuren, E., Park, J.-K., Dechend, R., Mervaala, E., Hampich, F., Fiebeler, A., Ju, X., Finckenberg, P., Theuer, J., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64445-8 · Cited by 278
Rodríguez-Iturbe, B., Vaziri, N. D., Herrera-Acosta, J., & Johnson, R. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00269.2003 · Cited by 277 · cited 1×
“Expression of angiotensin II has been observed in both tubular cells and a significant percentage of immune cells infiltrating the kidney in hypertensive animals”
BackgroundSelf-citationPreactivated Peripheral Blood Monocytes in Patients With Essential Hypertension
Dörffel, Y., Lätsch, C., Stuhlmüller, B., Schreiber, S., Scholze, S., Burmester, G. R., & Scholze, J. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.113 · Cited by 262
Rodríguez-Iturbe, B., Quiroz, Y., Nava, M., Bonet, L., Chávez, M., Herrera-Acosta, J., Johnson, R. J., & Pons, H. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0197.2001 · Cited by 261
Self-citationHeitzer, T., Wenzel, U., Hink, U., Krollner, D., Skatchkov, M., Stahl, R. A. K., Macharzina, R., Bräsen, J. H., Meinertz, T., & Münzel, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00229.x · Cited by 245
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
Rodríguez-Iturbe, B., Pons, H., Quiroz, Y., Gordon, K., Rincón, J., Chávez, M., Parra, G., Herrera-Acosta, J., Gómez-Garre, D., Largo, R., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00737.x · Cited by 241
Self-citationHypertension in cyclosporine-treated renal transplant recipients is sodium dependent
Curtis, J. J., Luke, R. G., Jones, P., & Diethelm, A. G. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80331-0 · Cited by 240
Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension
Vaziri, N. D., Liang, K., & Ding, Y. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00670.x · Cited by 238
Self-citationRoberts, C. K., Won, D., Pruthi, S., Kurtovic, S., Sindhu, R. K., Vaziri, N. D., & Barnard, R. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01292.2005 · Cited by 231 · cited 1×
“and hypertension in patients with metabolic syndrome is associated with increased plasma concentration of lipid peroxidation products”
BackgroundSelf-citationEvidence for Peroxynitrite Formation in the Vasculature of Women With Preeclampsia
Roggensack, A. M., Zhang, Y., & Davidge, S. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.83 · Cited by 227
Vaziri, N. D., Ni, Z., Oveisi, F., Liang, K., & Pandian, R. (2002) · Hypertension · doi:10.1161/hy0102.100540 · Cited by 224
Self-citationTouyz, R. M. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1302 · Cited by 222 · cited 1×
“and the cytosolic concentration of Ca 2+ , thereby increasing vascular smooth muscle tone, systemic vascular resistance and arterial pressure”
BackgroundUpregulation of renin-angiotensin system during differentiation of monocytes to macrophages
Okamura, A., Rakugi, H., Ohishi, M., Yanagitani, Y., Takiuchi, S., Moriguchi, K., Fennessy, P. A., Higaki, J., & Ogihara, T. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00012 · Cited by 221
Beswick, R. A., Zhang, H., Marable, D., Catravas, J. D., Hill, W. D., & Webb, R. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.781 · Cited by 221
Hydrogen peroxide as a potent activator of T lymphocyte functions
Los, M., Dröge, W., Stricker, K., Baeuerle, P. A., & Schulze‐Osthoff, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250127 · Cited by 220
Novel NAD(P)H oxidases in the cardiovascular system: Table 1
Griendling, K. K. (2004) · Heart · doi:10.1136/hrt.2003.029397 · Cited by 213
Ascorbic Acid Reduces Blood Pressure and Arterial Stiffness in Type 2 Diabetes
Mullan, B. A., Young, I. S., Fee, H., & McCance, D. R. (2002) · Hypertension · doi:10.1161/01.hyp.0000039961.13718.00 · Cited by 212 · cited 1×
“A few small trials have shown some reduction of blood pressure following administration of antioxidants such as vitamins C and E”
BackgroundHong, H.-J., Hsiao, G., Cheng, T.-H., & Yen, M.-H. (2001) · Hypertension · doi:10.1161/hy1101.095331 · Cited by 203
Lead-Induced Hypertension: Interplay of Nitric Oxide and Reactive Oxygen Species
Gonick, H. C., Ding, Y., Bondy, S. C., Ni, Z., & Vaziri, N. D. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1487 · Cited by 202
Self-citationHishikawa, K., Oemar, B. S., Yang, Z., & Lüscher, T. F. (1997) · Circulation Research · doi:10.1161/01.res.81.5.797 · Cited by 202
Effect of Antioxidant Therapy on Blood Pressure and NO Synthase Expression in Hypertensive Rats
Vaziri, N. D., Ni, Z., Oveisi, F., & Trnavsky-Hobbs, D. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.957 · Cited by 201
Self-citationDoes supplemental vitamin C increase cardiovascular disease risk in women with diabetes?
Lee, D.-H., Folsom, A. R., Harnack, L., Halliwell, B., & Jacobs, D. R. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1194 · Cited by 199 · cited 1×
“In fact, in some instances, long-term use of certain antioxidant agents has increased the risk of cancer and cardiovascular disease”
BackgroundVasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 198
Rodriguez-Iturbe, B., Zhan, C.-D., Quiroz, Y., Sindhu, R. K., & Vaziri, N. D. (2003) · Hypertension · doi:10.1161/01.hyp.0000052833.20759.64 · Cited by 191
Self-citationRole of increased oxygen free radical activity in the pathogenesis of uremic hypertension
Vaziri, N. D., Oveisi, F., & Ding, Y. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00947.x · Cited by 190
Self-citationPark, J. B., Touyz, R. M., Chen, X., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02233-6 · Cited by 189
Quiroz, Y., Pons, H., Gordon, K. L., Rincón, J., Chávez, M., Parra, G., Herrera-Acosta, J., Gómez-Garre, D., Largo, R., Egido, J., et al. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f38 · Cited by 167
Self-citationEnhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet
Roberts, C. K., Vaziri, N. D., Wang, X. Q., & Barnard, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.423 · Cited by 164
Self-citationEnhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool
Hehner, S. P., Breitkreutz, R., Shubinsky, G., Unsoeld, H., Schulze-Osthoff, K., Schmitz, M. L., & Dröge, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4319 · Cited by 162
Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by α-Lipoic Acid
Midaoui, A. E., & de Champlain, J. (2002) · Hypertension · doi:10.1161/hy0202.104345 · Cited by 160
Oxidative Stress Increases Endothelin-1 Synthesis in Human Coronary Artery Smooth Muscle Cells
Kähler, J., Ewert, A., Weckmüller, J., Stobbe, S., Mittmann, C., Köster, R., Paul, M., Meinertz, T., & Münzel, T. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200107000-00006 · Cited by 157
Suematsu, M., Suzuki, H., Delano, F. A., & Schmid‐Schönbein, G. W. (2002) · Microcirculation · doi:10.1038/sj.mn.7800141 · Cited by 156 · cited 1×
“It is notable that patients with essential hypertension exhibit upregulation of integrin expression and spontaneous degranulation of circulating granulocytes, indicating the presence of systemic inflammation”
BackgroundNava, M., Quiroz, Y., Vaziri, N. D., & Rodríguez‐Iturbe, B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00264.2002 · Cited by 154
Self-citationSuperoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats
Meng, S., Roberts, L. J., Cason, G. W., Curry, T. S., & Manning, R. D. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00346.2001 · Cited by 150
Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats
Duarte, J., Jiménez, R., O'Valle, F., Galisteo, M., Pérez-Palencia, R., Vargas, F., Pérez-Vizcaíno, F., Zarzuelo, A., & Tamargo, J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00031 · Cited by 150
Roberts, C. K., Barnard, R. J., Sindhu, R. K., Jurczak, M., Ehdaie, A., & Vaziri, N. D. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00463.2004 · Cited by 150
Self-citationAntioxidant‐mediated inhibition of the heat shock response leads to apoptosis
Gorman, A. M., Heavey, B., Creagh, E. M., Cotter, T. G., & Samali, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00094-0 · Cited by 146
Vaziri, N. D., Lin, C.-Y., Farmand, F., & Sindhu, R. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00711.x · Cited by 146
Self-citationRodríguez‐Iturbe, B., Ferrebuz, A., Vanegas, V., Quiroz, Y., Mezzano, S. A., & Vaziri, N. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088062 · Cited by 143
Self-citationStress proteins in inflammation
Polla, B. S., & Cossarizza, A. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9088-5_25 · Cited by 140
Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons
Fotherby, M. D., Williams, J. C., Forster, L. A., Craner, P., & Ferns, G. A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018040-00009 · Cited by 139
Chronic High Pressure-Induced Arterial Oxidative Stress
Ungvari, Z. I., Csiszár, A., Kaminski, P. M., Wolin, M. S., & Koller, Á. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63290-7 · Cited by 131
Ni, Z., Hou, S., Barton, C. H., & Vaziri, N. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66032.x · Cited by 124 · cited 1×
“Following incubation in media containing clinically relevant lead concentrations, NAD(P)H oxidase and ROS production were upregulated in cultured human endothelial and vascular smooth muscle cells”
MethodSelf-citationTian, N., Thrasher, K. D., Gundy, P. D., Hughson, M. D., & Manning, R. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000160404.08866.5a · Cited by 123
Evolution of Renal Interstitial Inflammation and NF-κB Activation in Spontaneously Hypertensive Rats
Rodríguez-Iturbe, B., Quiroz, Y., Ferrebuz, A., Parra, G., & Vaziri, N. D. (2004) · American Journal of Nephrology · doi:10.1159/000082313 · Cited by 117 · cited 1×
“In fact, tubulointerstitial accumulation of immune cells and NFκB activation are demonstrable in these rats prior to the onset of hypertension (at 3 weeks of age)”
BackgroundSelf-citationAlvarez, V., Quiroz, Y., Nava, M., Pons, H., & Rodríguez‐Iturbe, B. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00199.2002 · Cited by 115
Self-citationAntioxidant and redox regulation of cellular signaling: introduction
SEN, C. K. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200103000-00005 · Cited by 114 · cited 1×
“ROS have many important biological functions, such as regulation of redox-sensitive transcription factors, redox-sensitive signal transduction pathway”
BackgroundWhy are angiotensin concentrations so high in the kidney?
Navar, L. G., & Nishiyama, A. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200401000-00015 · Cited by 108
Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase
Hong, H.-J., Loh, S., & Yen, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703603 · Cited by 106
Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension
Barton, C. H., Ni, Z., & Vaziri, N. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031083.x · Cited by 100
Self-citationVitamin E can Reduce Blood Pressure in Mild Hypertensives
Boshtam, M., Rafiei, M., Sadeghi, K., & Sarraf-Zadegan, N. (2002) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.72.5.309 · Cited by 100
Dobrian, A. D., Schriver, S. D., & Prewitt, R. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.361 · Cited by 99
Wang, D., Chen, Y., Chabrashvili, T., Aslam, S., Borrego Conde, L. J., Umans, J. G., & Wilcox, C. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000090747.59919.d2 · Cited by 98 · cited 1×
“The defective vasodilatory response to acetylcholine is reversed by addition of the cell-permeable superoxide dismutase mimetic drug, tempol”
BackgroundKoo, J.-R., & Vaziri, N. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00728.x · Cited by 96
Self-citationEffect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation
Lenda, D. M., & Boegehold, M. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.0354.2001 · Cited by 92
Zhan, C.-D., Sindhu, R. K., & Vaziri, N. D. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00372.x · Cited by 89
Self-citationWang, D., Chabrashvili, T., & Wilcox, C. S. (2004) · Circulation Research · doi:10.1161/01.res.0000129578.76799.75 · Cited by 87 · cited 1×
“In addition, infusion of a slow pressor dose of angiotensin II leads to exaggerated angiotensin-II-induced vascular smooth muscle contraction that is primarily mediated via activation of thromboxane prostanoid receptors by a vasoconstrictive prostaglandin produced by cyclo-oxygenase 2”
BackgroundThe intrarenal renin-angiotensin system in hypertension
Navar, L. G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00539.x · Cited by 85
Benign and Malignant Hypertension and Nephrosclerosis: A Clinical and Pathological Study.
Kimmelstiel, P., & Wilson, C. (1936) · PubMed Central · Cited by 84
Renal Renin-Angiotensin System
Ichihara, A., Kobori, H., Nishiyama, A., & Navar, L. G. (2004) · Contributions to Nephrology · doi:10.1159/000078716 · Cited by 82
Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension
Mazzali, M., Jefferson, J. A., Ni, Z., Vaziri, N. D., & Johnson, R. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00011.x · Cited by 77
Self-citationDixon, L., HUGHES, S., ROONEY, K., MADDEN, A., Devine, A. B., Leahey, W. J., HENRY, W., Johnston, G. D., & McVeigh, G. E. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.01.004 · Cited by 77
Tare, M., Coleman, H. A., & Parkington, H. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h335 · Cited by 77
Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis
Vanegas, V., Ferrebuz, A., Quiroz, Y., & Rodríguez‐Iturbe, B. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00508.x · Cited by 76 · cited 1×
“The dissociation of intrarenal and plasma RASs is exemplified by the Page (cellophane wrap) kidney model in which development of interstitial nephritis and hypertension is associated with an increased concentration of renal angiotensin II but no change in plasma angiotensin II level”
BackgroundSelf-citationThe antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat
Zhang, Y. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.11.004 · Cited by 75
Pathogenesis of lead-induced hypertension: role of oxidative stress.
Vaziri, N. D. (2002) · PubMed · Cited by 75
Self-citationLead-induced hypertension. III. Increased hydroxyl radical production
Ding, Y. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01248-6 · Cited by 67
Nitric Oxide Synthase Expression in Hypertension Induced by Inhibition of Glutathione Synthase
Zhou, X. J., Vaziri, N. D., Wang, X. Q., Silva, F. G., & Laszik, Z. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.762 · Cited by 61 · cited 1×
“Finally, induction of oxidative stress causes hypertension in genetically normal and otherwise healthy animals”
BackgroundSelf-citationSironi, L., Gelosa, P., Guerrini, U., Banfi, C., Crippa, V., Brioschi, M., Gianazza, E., Nobili, E., Gianella, A., de Gasparo, M., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072066 · Cited by 60
Stress Proteins in Inflammationa
Polla, B. S., Bachelet, M., Elia, G., & SANTORO, M. G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08979.x · Cited by 59 · cited 1×
“which in turn stimulate production of pro-inflammatory cytokines and expression of the adhesion molecules E-selectin, intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1)”
BackgroundZalba, G., Beaumont, J., José, G. S., Fortuño, A., Fortuño, M. A., & Dı́ez, J. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.2 · Cited by 58
Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression
Nickenig, G., Strehlow, K., Bäumer, A. T., Baudler, S., Waßmann, S., Sauer, H., & Böhm, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703623 · Cited by 55 · cited 1×
“The negative feedback regulation of the AT 1 receptor by angiotensin II is largely mediated by ROS”
BackgroundEffects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expression
Sindhu, R. K., Roberts, C. K., Ehdaie, A., Zhan, C.-D., & Vaziri, N. D. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.10.014 · Cited by 48
Self-citationImmune cell CD62L and CD11a expression in response to a psychological stressor in human hypertension
Mills, P. J., Farag, N. H., Hong, S., Kennedy, B. P., Berry, C. C., & Ziegler, M. G. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00055-2 · Cited by 39 · cited 1×
“It is notable that patients with essential hypertension exhibit upregulation of integrin expression and spontaneous degranulation of circulating granulocytes, indicating the presence of systemic inflammation”
BackgroundTsukahara, H., Hiraoka, M., Kobata, R., Hata, I., Ohshima, Y., Jiang, M., Noiri, E., & Mayumi, M. (2000) · Redox Report · doi:10.1179/rer.2000.5.1.23 · Cited by 33
Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation
Vaziri, N. D., & Ni, Z. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.03.003 · Cited by 31
Self-citationTsukahara, H., HARUTA, T., Ono, N., Kobata, R., Fukumoto, Y., Hiraoka, M., & Mayumi, M. (2000) · Redox Report · doi:10.1179/135100000101535834 · Cited by 30
Rodríguez‐Iturbe, B., Quiroz, Y., KIM, C., & Vaziri, N. D. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.034 · Cited by 27
Self-citationThe clinical diagnosis of hypertensive nephrosclerosis - how reliable is it?
Caetano, E. R. S. P. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.2.288 · Cited by 16
ANALGESIC ABUSE AND HYPERTENSION
Küster, G., & Ritz, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91125-2 · Cited by 13
Caimi, G., Presti, R. L., Carollo, C., Musso, M., Porretto, F., Canino, B., Catania, A., & Cerasola, G. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.813 · Cited by 12
Research works printed but not linked: 3
- Nava M et al. (2003) Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284: F447–F454 · DOI
- Beswick RA et al. (2001) Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781–786 · DOI · Paper page
- Rodríguez-Iturbe B et al. (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341–346 · DOI · Paper page
Cited by
Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
Biswas, S. K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5698931 · Cited by 1,166
“Conversely, if inflammation is the primary event, oxidative stress will develop as a consequence which will further exaggerate inflammation [69].”
BackgroundDiabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
“Conversely, if inflammation is the main event, oxidative stress will develop as a consequence which will further exaggerate the inflammation [68].”
BackgroundNADPH Oxidases, Reactive Oxygen Species, and Hypertension
Paravicini, T. M., & Touyz, R. M. (2008) · Diabetes Care · doi:10.2337/dc08-s247 · Cited by 724
Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Self-citationOxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
“It is well established that Ang II increases oxidative and inflammation, factors that are critically associated with renal pathogenesis, particularly due to hypertension and diabetes (258,306).”
Metadata
- Authors
- Vaziri, N. D., & Rodríguez-Iturbe, B.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Vaziri, Nosratola D
- ORCID
- Vaziri, Nosratola D
- Venue
- Nature Clinical Practice Nephrology
- Published
- 2006-10
- Volume
- 2
- Issue
- 10
- Pages
- 582-593
- ISSN
- 1745-8323 (ISSN-L)
- 1745-8331
- OpenAlex
- W1990296073
- Cited by
- 442
- References
- 127
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 23 · 2023: 12 · 2022: 31 · 2021: 34 · 2020: 33 · 2019: 20 · 2018: 22 · 2017: 23 · 2016: 17 · 2015: 18 · 2014: 18 · 2013: 22 · 2012: 25
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- hypertension pathogenesis, oxidative stress, inflammation, reactive oxygen species, antioxidants, cytokines, malignant hypertension, accelerated hypertension, salt-sensitive hypertension, target organ damage, cardiovascular disease, renal complications
- MeSH terms
- Animals, Humans, Hypertension, Inflammation, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.